Order Article Reprints

Garcia-Cremades M, Hendrix CW, Jayachandran P, Strydom N, Jarlsberg L, Grant R, Celum CL, Martin M, Baeten JM, Marrazzo J, et al. Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis. Pharmaceutics. 2022; 14(9):1801. https://doi.org/10.3390/pharmaceutics14091801

Garcia-Cremades, Maria, Craig W. Hendrix, Priya Jayachandran, Natasha Strydom, Leah Jarlsberg, Robert Grant, Connie L. Celum, Michael Martin, Jared M. Baeten, Jeanne Marrazzo, and et al. 2022. "Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis" Pharmaceutics 14, no. 9: 1801. https://doi.org/10.3390/pharmaceutics14091801

Garcia-Cremades, M., Hendrix, C. W., Jayachandran, P., Strydom, N., Jarlsberg, L., Grant, R., Celum, C. L., Martin, M., Baeten, J. M., Marrazzo, J., Anderson, P., Choopanya, K., Vanichseni, S., Glidden, D. V., & Savic, R. M. (2022). Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis. Pharmaceutics, 14(9), 1801. https://doi.org/10.3390/pharmaceutics14091801